Top compounds associated with response to RP11-302B13.5


Feature Type Standardized
Nominal ANOVA
mRNA cediranib CTRPv2 pan-cancer AAC -0.059 0.3
mRNA PX-12 CTRPv2 pan-cancer AAC -0.032 0.3
mRNA SU11274 CTRPv2 pan-cancer AAC -0.039 0.3
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.039 0.3
mRNA HBX-41108 CTRPv2 pan-cancer AAC 0.046 0.3
mRNA fingolimod CTRPv2 pan-cancer AAC -0.039 0.3
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.039 0.3
mRNA vorapaxar CTRPv2 pan-cancer AAC -0.041 0.3
mRNA CD-1530 CTRPv2 pan-cancer AAC -0.041 0.3
mRNA CHEMBL1222381 CTRPv2 pan-cancer AAC 0.036 0.3
Download CSV